MSC Trial: Stem-Cell Therapy for Ischemic HF Inches Forward – Medscape
|
MSC Trial: Stem–Cell Therapy for Ischemic HF Inches Forward
Medscape They had been assigned to receive intramyocardial injections of autologous mesenchymal stromal cells (MSC), a kind of stem cell, for their ischemic heart disease. After six months, their proportion of functional heart muscle had gone up along with LV … |
